EBASTINE STADA 10 MG FILM-COATED TABLETS EFG
SpainIt is used to treat allergic processes such as allergic rhinitis (seasonal or perennial) with or without allergic conjunctivitis (causing runny nose, itching of the nose or eyes, tearing, and sneezing), chronic urticaria, and allergic dermatitis.
Frequently asked questions
How should I take Ebastina Stada 10 mg?
Adults and children over 12 years of age should take 1 tablet daily. Children between 6 and 11 years of age should take half a tablet daily. The tablets should be swallowed whole with a glass of water, with or without food.
When should I not take this medication?
It should not be taken if you are allergic to any of its components. It should also not be used for acute emergency allergic conditions, as it takes between 1 and 3 hours to take effect. It should not be administered to children under 12 years of age (except for the specific dose for children aged 6 to 11 mentioned above) and should be avoided during breastfeeding.
What side effects can Ebastina Stada 10 mg cause?
The most common side effects are headache, drowsiness, and dry mouth. Other possible effects include dizziness, nausea, digestive problems, palpitations, changes in taste or sensitivity, and allergic reactions.
Can I take other medications while using this product?
You must inform your doctor if you are taking other medications, especially other antihistamines, antifungals (such as ketoconazole or itraconazole), or antibiotics such as erythromycin or rifampicin, as they may interfere with the effect of the treatment.
Should I be cautious when driving or using machinery?
Since this medication may cause drowsiness or dizziness, it is recommended to observe how it affects you before performing these activities.
What should I do if I forget a dose?
If you forget a dose, take it as soon as you remember, unless it is almost time for your next dose, in which case you should wait and continue with your usual schedule. Do not take a double dose to make up for the forgotten one.
Instructions for use
Table of contents
- Introduction
- 1. What Ebastina Stada 10 mg tablets are and what they are used for
- 2. What you need to know before taking Ebastina Stada 10 mg tablets
- 3. How to take Ebastine Stada 10 mg tablets
- 4. Possible adverse effects
- 5. Storage of Ebastine Stada 10 mg Tablets
- 6. Contents of the pack and other information
Package leaflet: Information for the user
Introduction
Package leaflet: Information for the user
Ebastina STADA 10 mg film-coated tablets EFG
Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.
- Keep this leaflet; you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, because it could harm them.
- If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
Leaflet contents:
-
What Ebastina STADA 10 mg tablets are and what they are used for
-
What you need to know before taking Ebastina STADA 10 mg tablets
-
How to take Ebastina STADA 10 mg tablets
-
Possible side effects
-
How to store Ebastina STADA 10 mg tablets
-
Contents of the pack and other information
1. What Ebastina Stada 10 mg tablets are and what they are used for
Ebastine, the active component of Ebastina Stada 10 mg, belongs to a group of medicines known as antihistamines (antiallergic agents).
Ebastina Stada 10 mg is indicated for the treatment of allergic conditions such as seasonal or perennial allergic rhinitis associated or not with allergic conjunctivitis (such as runny nose, nasal itching, eye itching, tearing, sneezing), chronic urticaria, and allergic dermatitis.
2. What you need to know before taking Ebastina Stada 10 mg tablets
Do not take Ebastina Stada 10 mg:
- if you are allergic to the active substance or to any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Talk to your doctor or pharmacist before taking Ebastina Stada.
This medicine should be used with caution:
- if your electrocardiogram (ECG) results are abnormal (prolongation of the QT interval).
- if you have high levels of potassium in your blood.
- if you suffer from severe liver disease (see section “How to take Ebastina Stada”).
- if you are being treated with a type of medicine used to treat fungal infections called azole antifungals, or with medicines used to treat certain infections called macrolide antibiotics (see section “Other medicines and Ebastina Stada 10 mg”).
- if you are being treated with rifampicin, a medicine used to treat tuberculosis.
Do not use this medicine if you have an acute allergic emergency, as ebastine (the active ingredient in this medicine) takes 1 to 3 hours to take effect.
Children
Ebastina Stada must not be given to children under 12 years of age.
Other medicines and Ebastina Stada 10 mg
Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
The following medicines may interact with ebastine; in such cases, it may be necessary to adjust the dose or discontinue treatment with one of them:
- Ebastine may increase the effect of other medicines used to treat allergies (antihistamines).
- Ebastine should be used with caution in patients taking medicines called ketoconazole and itraconazole, used to treat fungal infections, or with an antibiotic used to treat certain infections called erythromycin (as they may cause changes in your ECG).
- The antihistaminic effect of ebastine may be reduced in patients taking a medicine called rifampicin, used to treat tuberculosis.
No interactions have been reported between ebastine and theophylline, warfarin, cimetidine, diazepam, or alcohol.
Interference with diagnostic tests
Ebastina Stada may interfere with the results of skin allergy tests; therefore, such tests should not be performed until 5–7 days after stopping treatment.
Taking Ebastina Stada 10 mg with food and drink
The tablets may be taken with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
There is no experience in pregnant women; therefore, it is recommended to consult a doctor before taking Ebastina Stada. The doctor will decide whether or not treatment should be started.
Breastfeeding
It is unknown whether the medicine passes into breast milk; therefore, it should not be used during breastfeeding.
Driving and using machines
At the recommended therapeutic doses, no effects on psychomotor function or on the ability to drive or operate machinery have been observed in humans. However, since somnolence and dizziness are listed among the adverse effects, you should assess your response to the medication before driving or operating machinery.
Important information about some of the ingredients of Ebastina Stada
This medicine does not contain gluten.
Ebastina Stada contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; thus, it is essentially “sodium-free”.
3. How to take Ebastine Stada 10 mg tablets
Follow exactly the instructions for use of this medicine as given by your doctor. If in doubt, consult your doctor or pharmacist again.
Your doctor will determine the duration of your treatment with Ebastine Stada 10 mg. Do not stop the treatment prematurely, as your symptoms may worsen.
Remember to take your medicine.
Dosage
Use in adults and children over 12 years of age: The recommended dose is 1 tablet (10 mg of ebastine) once daily.
Use in children between 6 and 11 years of age: The recommended dose is half a tablet (5 mg) once daily.
Use in patients with severe liver disease: The dose should not exceed 10 mg of ebastine per day (1 tablet).
Method of administration
This medicine is for oral use.
The tablets should be swallowed whole, without chewing, with a glass of liquid, preferably water.
If you think that the effect of Ebastine Stada 10 mg is too strong or too weak, inform your doctor or pharmacist.
If you take more Ebastine Stada 10 mg than you should
In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at telephone number: 91 562 04 20, indicating the medicine and the amount taken.
Treatment of poisoning with this medicine consists of gastric lavage and administration of appropriate medication. Take this leaflet with you.
If you forget to take Ebastine Stada 10 mg
Do not take a double dose to make up for missed doses. Take the missed dose as soon as you remember, then continue with your regular schedule. However, if it is almost time for your next dose, do not take the missed dose and wait until the next scheduled dose.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine may cause adverse effects, although not everyone will experience them.
The following adverse effects have been observed in clinical trials and post-marketing experience:
Very common (may affect more than 1 in 10 people):
- headache
Common (may affect up to 1 in 10 people):
- somnolence
- dry mouth
Rare (may affect up to 1 in 1,000 people):
- hypersensitivity reactions: allergic reactions (such as anaphylaxis and angioedema)
- nervousness, insomnia
- dizziness, decreased sensation or sensitivity, decreased or altered taste
- palpitations, tachycardia
- abdominal pain, vomiting, nausea, digestive problems
- liver inflammation (hepatitis), cholestasis, abnormal liver function tests (increased transaminases, gamma-GT, alkaline phosphatase and bilirubin)
- urticaria, skin rash, dermatitis
- menstrual disorders
- edema (swelling due to fluid accumulation), fatigue
Frequency not known (cannot be estimated from available data):
- weight gain
- increased appetite
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Ebastine Stada 10 mg Tablets
Keep this medicine out of sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. Ask your pharmacist how to dispose of medicines and containers you no longer need. This will help protect the environment.
6. Contents of the pack and other information
Composition of Ebastina Stada 10 mg
-
The active substance is ebastine. Each tablet contains 10 mg of ebastine.
-
The other components are microcrystalline cellulose, stearoyl macroglycolide glycerides, sodium starch glycolate (potato starch) gluten-free, magnesium stearate, purified water, Opadry white.
Appearance of the product and contents of the pack
Ebastina Stada 10 mg tablets are oblong, biconvex, white tablets with a score line. The tablet can be divided into equal halves.
Packs contain 20 tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Laboratorio STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona), Spain
Manufacturer:
Generis Farmacêutica S.A.
Rua João de Deus nº 19, Venda Nova
2700-487 Amadora
Portugal
Date of the most recent revision of this leaflet: May 2019
Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Similar drugs
The original data is available in the language of the country of manufacture.
Data source: Online Medicines Information Centre (CIMA) — AEMPS
Data last verified: September 21, 2026